BRIDGE MEDICINES
Bridge Medicines is a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Bridge Medicines is a groundbreaking initiative that completes an unbroken, fully funded and professionally staffed path from concept to drug candidate, to develop efficiently and quickly innovative therapeutics for the treatment of human diseases.
BRIDGE MEDICINES
Industry:
Pharmaceutical
Founded:
2016-01-01
Address:
Sioux Falls, South Dakota, United States
Country:
United States
Website Url:
http://www.bridgemedicines.com
Total Employee:
11+
Status:
Active
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default WordPress Wordpress Plugins Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Cyagen Biosciences
Cyagen Biosciences is an emerging and innovative biotechnology company.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Employees Featured
Investors List
Takeda
Takeda investment in Venture Round - Bridge Medicines
Bay City Capital
Bay City Capital investment in Venture Round - Bridge Medicines
Deerfield
Deerfield investment in Venture Round - Bridge Medicines
Deerfield
Deerfield investment in Venture Round - Bridge Medicines
Bay City Capital
Bay City Capital investment in Venture Round - Bridge Medicines
Takeda
Takeda investment in Venture Round - Bridge Medicines
Official Site Inspections
http://www.bridgemedicines.com Semrush global rank: 6 M Semrush visits lastest month: 1.36 K
- Host name: 209.182.198.166
- IP address: 209.182.198.166
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Bridge Medicines"
ABOUT US - Bridge Medicines
ABOUT US Bridge Medicines biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare …See details»
MEET THE TEAM - Bridge Medicines
MEET THE TEAM Our team is built of experienced scientists, biopharma industry veterans, entrepreneurs, pioneers and pirates. We balance a spirit of exploration with an intense …See details»
Bridge Medicines - Crunchbase Company Profile & Funding
Bridge Medicines is a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda …See details»
Bridge Medicines Company Profile | Management and Employees …
Bridge Medicines is a pioneering drug-discovery company focused on advancing promising early technologies in major academic institutions from proof-of-concept to clinical development. The …See details»
Bridge Medicines - Overview, News & Similar companies
Nov 11, 2020 View Bridge Medicines (www.bridgemedicines.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as …See details»
bridgemedicines.com - Bridge Medicines – Acceleratin... - Bridge …
Bridgemedicines.com. MEET BRIDGE MEDICINES Bridge Medicines biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, ...See details»
Bridge Medicines - Biotech Careers
Bridge Medicines is a fully funded, professionally staffed biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell …See details»
Bridge Medicines LLC - Drug pipelines, Patents, Clinical trials
Explore Bridge Medicines LLC with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Hemic and Lymphatic Diseases, Neoplasms, Technology …See details»
Bridge Medicines - VentureRadar
Bridge Medicines biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company …See details»
Partners – Bridge Medicines
We succeed by working together. In order to bring innovative therapeutics through an unbroken and fully funded path from concept to proven treatment of human diseases, we leverage the unique positions, skills, ethos and investing …See details»
Bridge Medicines LLC | CipherBio
Explore Bridge Medicines LLC's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Bridge Medicines Adds Small Molecule Inhibitors of Activated
Sep 21, 2020 Bridge Medicines and The Rockefeller University today announced an exclusive license agreement to further develop a series of small molecule inhibitors of activated Factor …See details»
Bridge Medicines | Insights
The number of biopharmaceutical companies that have gone public in the US in 2024 has now beat the 2023 total of 21 with the 10 October initial public offerings by Upstream Bio Inc. and …See details»
Contact – Bridge Medicines
Accelerating the Path to the Patient HEADQUARTERS Jacob S. Lasdon House 420 East 70th Street, Suite 510 New York, NY 10021 GENERAL INQUIRIES [email protected]See details»
Bridge Medicines Accepts Novel Small Molecule Targeting Basal …
Mar 14, 2018 New York, NY /PRNewswire/ - Bridge Medicines and the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) announced today the acceptance into Bridge …See details»
Bridge Medicines-动脉网 - vbdata.cn
Bridge Medicines是一家药物发现公司，与Memorial Sloan Kettering癌症中心，洛克菲勒大学，威尔康奈尔医学，武田制药有限公司以及医疗保健投资公司Bay City Capital和Deerfield …See details»
Pipeline – Bridge Medicines
Our mission is to move breakthrough research to the patient by bringing the best in modern drug discovery to the service of academic medicine. By eliminating roadblocks like loss of control of …See details»
Bridge Medicines LLC (Bridge Medicines LLC) - 药物管线_专利_临 …
了解Bridge Medicines LLC (Bridge Medicines LLC)公司的药物管线，治疗领域，技术平台，以及它的3篇新闻，疾病领域:血液及淋巴系统疾病，肿瘤，技术平台:化学药，药物:TDI-11055。See details»
News & Media – Bridge Medicines
Mar 16, 2020 Bridge Medicines Enters Exclusive License Agreement with Cornell University for UBR5 Inhibitor Program to Treat Resistant Cancers July 28, 2021See details»